Articles Tagged With:
-
Colchicine Tablets (Lodoco)
The FDA has approved the first anti-inflammatory drug to lower the risk of cardiovascular events occurring in adults with established atherosclerotic disease or with multiple risk factors.
-
Mothers, Babies, and HPV: Thanks for Not Sharing!
Nearly half of pregnant women in a Canadian study had vaginal swabs positive for human papillomavirus (HPV) deoxyribonucleic acid (DNA). Only about one-fourth of placentas and newborns produced by those HPV-positive women carried detectable HPV DNA, and all HPV-positive babies had cleared their positivity by 6 months of age.
-
Cabergoline: An Effective Intervention for Unwanted Lactation After Second Trimester Uterine Evacuation
In this double-blind, randomized controlled trial among 73 patients between 18 and 28 weeks’ gestation undergoing dilation and evacuation or induction of labor for abortion or fetal demise, a one-time dose of 1 mg of cabergoline compared to placebo reduced post-delivery lactation-related breast symptoms in the treatment arm (27.8% vs. 97.0%; relative risk, 0.05; 95% confidence interval, 0.01-0.33).
-
Effectiveness and Safety of Low-Dose Aspirin to Prevent Preterm Preeclampsia
An aspirin dosage of 150 mg to 162 mg per day, when started in the first trimester of pregnancy, was linked to a decreased risk of preterm preeclampsia compared to an aspirin dosage of 75 mg to 81 mg per day.
-
Is It Safe to Skip the Pelvic Examination Before Gender-Affirming Hysterectomy and Vaginectomy?
A retrospective chart review of individuals undergoing gender-affirming hysterectomy, vaginectomy, or both found no difference in 30-day perioperative outcomes between those who received a preoperative internal pelvic examination and those who did not. These findings indicate that omitting such potentially triggering exams may be safe.
-
Tips for Making ‘Tele-Ethics’ Work
Even after the pandemic, medical facilities continue leveraging virtual health technology.
-
Abortion Bans Lead Physicians, Nurses to Avoid Certain States
Medical students, residents, and practicing OB/GYNs are saying they do not want to train and practice in states with extreme abortion bans, including Texas, Arkansas, Louisiana, Tennessee, Oklahoma, and others. The authors of a recent study found that four in five physicians and trainees preferred to avoid working in states with abortion bans.
-
Stress, Burnout, Quitting May Increase in Coming Years
Nurses, physicians, and others who work in reproductive healthcare are under increasing stress and pressure since states began to enforce abortion laws that range from total bans to restrictions on most abortion care. The authors of a recent study found that abortion providers are burdened and affected emotionally when they help people who are turned away from abortion care in their own communities or state.
-
Patients Face Barriers to Permanent Contraception
For people who want a permanent contraception method, both tubal surgery and vasectomy are safe, highly effective, and result in a quick recovery. The chief obstacles are insurance restrictions, finding a clinician who can do the procedure, securing an operating room, religious hospitals’ policies, and inconvenience to patients.
-
Base Permanent Contraception Counseling on Patients’ Preferences
Increasingly, reproductive health providers are meeting with patients who are interested in a permanent contraceptive method. Roadblocks to these procedures include a patient’s personal concerns about the procedure or future regret, as well as insurance/cost concerns, and clinicians who turn them down because they are too young or have no or too few children.